RecA inactivation as a strategy to reverse the heteroresistance phenomenon in clinical isolates of Escherichia coli-Reference-Cited by-同舟云学术

RecA inactivation as a strategy to reverse the heteroresistance phenomenon in clinical isolates of Escherichia coli

Published:2023-02 Issue:2 Volume:61 Page:106721
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Diaz-Diaz S.^ORCID,Yerbes Pilar,Recacha E.^ORCID,de Gregorio-Iaria B.,Pulido Marina R.^ORCID,Romero-Muñoz María,Docobo-Pérez F.,Pascual A.,Rodríguez-Martínez J.M.^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference40 articles.

1. Environmental and genetic modulation of the phenotypic expression of antibiotic resistance;Hughes;FEMS Microbiol Rev,2017

2. Mode of action of streptomycin on type b H. influenzae: I. Origin of resistant organisms;Alexander;J Exp Med,1947

3. Mechanisms and clinical relevance of bacterial heteroresistance;Andersson;Nat Rev Microbiol,2019

4. Contribution of hypermutation to fosfomycin heteroresistance in Escherichia coli;Portillo-Calderón;J Antimicrob Chemother,2020

5. Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii;Fernández Cuenca;Int J Antimicrob Agents,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection and characterization of eravacycline heteroresistance in clinical bacterial isolates;Frontiers in Microbiology;2024-03-27

2. RpoS role in antibiotic resistance, tolerance and persistence in E. coli natural isolates;BMC Microbiology;2024-03-05